These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 17924980
1. Glutamate receptor expression in multiple sclerosis lesions. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, Smith T. Brain Pathol; 2008 Jan; 18(1):52-61. PubMed ID: 17924980 [Abstract] [Full Text] [Related]
2. The link between excitotoxic oligodendroglial death and demyelinating diseases. Matute C, Alberdi E, Domercq M, Pérez-Cerdá F, Pérez-Samartín A, Sánchez-Gómez MV. Trends Neurosci; 2001 Apr; 24(4):224-30. PubMed ID: 11250007 [Abstract] [Full Text] [Related]
3. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Pitt D, Nagelmeier IE, Wilson HC, Raine CS. Neurology; 2003 Oct 28; 61(8):1113-20. PubMed ID: 14581674 [Abstract] [Full Text] [Related]
4. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ouardouz M, Coderre E, Zamponi GW, Hameed S, Yin X, Trapp BD, Stys PK. Ann Neurol; 2009 Feb 28; 65(2):160-6. PubMed ID: 19224531 [Abstract] [Full Text] [Related]
6. AMPA receptors are the major mediators of excitotoxic death in mature oligodendrocytes. Leuchtmann EA, Ratner AE, Vijitruth R, Qu Y, McDonald JW. Neurobiol Dis; 2003 Dec 28; 14(3):336-48. PubMed ID: 14678751 [Abstract] [Full Text] [Related]
8. Differences in ionotropic glutamate receptor subunit expression are not responsible for strain-dependent susceptibility to excitotoxin-induced injury. Schauwecker PE. Brain Res Mol Brain Res; 2003 Apr 10; 112(1-2):70-81. PubMed ID: 12670704 [Abstract] [Full Text] [Related]
9. Glutamate receptors in pediatric tumors of the central nervous system. Brocke KS, Staufner C, Luksch H, Geiger KD, Stepulak A, Marzahn J, Schackert G, Temme A, Ikonomidou C. Cancer Biol Ther; 2010 Mar 15; 9(6):455-68. PubMed ID: 20061814 [Abstract] [Full Text] [Related]
10. Expression of AMPA/kainate receptors during development of chick embryo retina cells: in vitro versus in vivo studies. Cristóvão AJ, Oliveira CR, Carvalho CM. Int J Dev Neurosci; 2002 Feb 15; 20(1):1-9. PubMed ID: 12008069 [Abstract] [Full Text] [Related]
12. Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Wosik K, Ruffini F, Almazan G, Olivier A, Nalbantoglu J, Antel JP. Brain; 2004 Dec 15; 127(Pt 12):2636-48. PubMed ID: 15509624 [Abstract] [Full Text] [Related]
13. Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis? Werner P, Pitt D, Raine CS. J Neural Transm Suppl; 2000 Dec 15; (60):375-85. PubMed ID: 11205156 [Abstract] [Full Text] [Related]
14. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Domercq M, Etxebarria E, Pérez-Samartín A, Matute C. Glia; 2005 Oct 15; 52(1):36-46. PubMed ID: 15892126 [Abstract] [Full Text] [Related]
15. Increased expression and function of glutamate transporters in multiple sclerosis. Vallejo-Illarramendi A, Domercq M, Pérez-Cerdá F, Ravid R, Matute C. Neurobiol Dis; 2006 Jan 15; 21(1):154-64. PubMed ID: 16061389 [Abstract] [Full Text] [Related]
17. Type-2 astrocyte-like cells are more resistant than oligodendrocyte-like cells against non-N-methyl-D-aspartate glutamate receptor-mediated excitotoxicity. Yamaya Y, Yoshioka A, Saiki S, Yuki N, Hirose G, Pleasure D. J Neurosci Res; 2002 Nov 15; 70(4):588-98. PubMed ID: 12404513 [Abstract] [Full Text] [Related]
18. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Omari KM, John G, Lango R, Raine CS. Glia; 2006 Jan 01; 53(1):24-31. PubMed ID: 16086366 [Abstract] [Full Text] [Related]
19. Mechanical loading modulates glutamate receptor subunit expression in bone. Szczesniak AM, Gilbert RW, Mukhida M, Anderson GI. Bone; 2005 Jul 01; 37(1):63-73. PubMed ID: 15922681 [Abstract] [Full Text] [Related]